Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daptomycin vs Comparator in Pediatric Acute Hematogenous Osteomyelitis
NCT01922011Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Sep 2013
- Primary completion
- Jun 2016
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
01
Overview
A Phase 3 trial of daptomycin in acute hematogenous osteomyelitis (AHO), sponsored by Merck & Co.. Started Sep 2013; status: completed.
02
Drugs
daptomycin
03
Conditions
acute hematogenous osteomyelitis (AHO)
Beyond the preview
Go deeper on NCT01922011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01922011.